Date Filed | Type | Description |
06/21/2022 |
4
| Exter Neil (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 10,000 options to buy
@ $2.3, valued at
$23k
|
|
06/21/2022 |
4
| Exter Neil (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 15,000 options to buy
@ $6.8, valued at
$102k
|
|
06/17/2022 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Granted 5,200 shares
@ $0 Granted 18,400 options to buy
@ $16.8, valued at
$309.1k
|
|
06/10/2022 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc. |
06/30/2021 |
4
| Exter Neil (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
06/24/2021 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Granted 3,617 shares
@ $0 Granted 12,659 options to buy
@ $32.93, valued at
$416.9k
|
|
06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2021 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc. |
02/19/2021 |
4
| Exter Neil (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Converted 2,938,945 shares
@ $0 Converted 98,929 shares
@ $0 Converted 54,642 shares
@ $0 Converted 45,638,882 preferred shares
@ $0 Converted 1,250,000 preferred shares
@ $0 Converted 289,603 preferred shares
@ $0 |
|
02/19/2021 |
3/A
| Exter Neil (10% Owner) has filed a Form 3/A on Decibel Therapeutics, Inc. |
02/16/2021 |
4
| Exter Neil (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $18, valued at
$360k
|
|
02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/04/2020 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc. |
09/11/2020 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc. |
06/09/2020 |
4
| Exter Neil (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns:
| Granted 26,573 options to buy
@ $0 Converted preferred shares
@ $0 |
|
06/02/2020 |
3
| Exter Neil (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
02/20/2020 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Converted convertible preferred
@ $0 |
|
02/14/2020 |
4
| Exter Neil (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Granted 36,168 options to buy
@ $17, valued at
$614.9k
|
|
02/12/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/08/2018 |
4
| Exter Neil (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $34.89, valued at
$348.9k
|
|
10/12/2017 |
4
| Exter Neil (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Converted convertible preferred
@ $0 Converted options to buy
@ $0 |
|
10/04/2017 |
3
| Exter Neil (Director) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC. |
06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/14/2016 |
4
| Exter Neil (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 14,000 options to buy
@ $10.17, valued at
$142.4k
|
|